TenX Protocols Income Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025
Revenue	0.24	0.14	0.05	0
Revenue Growth	-	203.56%	2239.48%	-
Gross Profit	0.24	0.14	0.05	0
Selling, General & Admin	3.49	2.88	1.07	0.36
Operating Expenses	3.63	3.01	1.11	0.36
Operating Income	-3.39	-2.87	-1.07	-0.36
Interest & Investment Income	0.02	0.02	-	-
Currency Exchange Gain (Loss)	0.01	-0.02	-0.01	0
Other Non Operating Income (Expenses)	-16	-13.92	-1.39	-0.43
EBT Excluding Unusual Items	-19.35	-16.79	-2.47	-0.79
Gain (Loss) on Sale of Investments	-0.08	-0.03	-	-
Asset Writedown	-0.23	-0.23	-	-
Other Unusual Items	-0.91	-0.88	-	-
Pretax Income	-20.56	-17.92	-2.47	-0.79
Net Income	-20.56	-17.92	-2.47	-0.79
Net Income to Common	-20.56	-17.92	-2.47	-0.79
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	45	34	21	7
Shares Outstanding (Diluted)	45	34	21	7
Shares Change	-	67.29%	183.00%	-
EPS (Basic)	-0.46	-0.52	-0.12	-0.11
EPS (Diluted)	-0.46	-0.52	-0.12	-0.11
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Margin	-1407.07%	-2010.67%	-2269.70%	-18023.62%
Profit Margin	-8546.38%	-12550.50%	-5252.81%	-39532.07%
EBITDA	-	-2.74	-	-
D&A For EBITDA	-	0.14	-	-
EBIT	-3.39	-2.87	-1.07	-0.36
Advertising Expenses	-	0.22	-	-